8,255 followers
https://t.co/bH41NLSp9g Fabricación Escalable de células T CAR para Inmunoterapia contra el Cáncer
225 followers
1,132 followers
203 followers
4,095 followers
197 followers
2,972 followers
If you are watching #AACR22 session "Adoptive Cellular Therapy: Treatment for the Masses," then check out relevant Blood Cancer Discovery review on scalability of #CART cell production by @abouelem, @ElsallabMagdi et al: https://t.co/BUbRkCCnrP https://t.c
2,972 followers
#ICYMI: Scalable Manufacturing of CAR T Cells for Cancer Immunotherapy. https://t.co/Q5tfZxBfYz @abouelem @ElsallabMagdi #CARTcell https://t.co/MQdh8ocwr9
2,773 followers
RT @ElsallabMagdi: Very happy to share our latest review on scaling the manufacturing of CAR T cells that was published in @BCD_AACR. I hop…
2,972 followers
RT @ElsallabMagdi: Very happy to share our latest review on scaling the manufacturing of CAR T cells that was published in @BCD_AACR. I hop…
1,132 followers
RT @ElsallabMagdi: Very happy to share our latest review on scaling the manufacturing of CAR T cells that was published in @BCD_AACR. I hop…
203 followers
Very happy to share our latest review on scaling the manufacturing of CAR T cells that was published in @BCD_AACR. I hope this work serves as a starting point for investigators who are interested in transferring their CAR-Ts to the clinic. https://t.co/619
2,972 followers
Read the recently published, related, review article: Scalable Manufacturing of CAR T Cells for Cancer Immunotherapy. https://t.co/WI2yGCVvzv.
1,052 followers
RT @abouelem: Our recent review on CAR T cell manufacturing is out in @BCD_AACR. We provide a comprehensive overview on recent trends and a…
2,972 followers
From the September issue: A review article Scalable Manufacturing of CAR T Cells for Cancer Immunotherapy. https://t.co/uiis6CMSRT @abouelem @ElsallabMagdi #CARTcell https://t.co/KoNhKIhtPY
428 followers
RT @abouelem: Our recent review on CAR T cell manufacturing is out in @BCD_AACR. We provide a comprehensive overview on recent trends and a…
848 followers
RT @abouelem: Our recent review on CAR T cell manufacturing is out in @BCD_AACR. We provide a comprehensive overview on recent trends and a…
662 followers
RT @abouelem: Our recent review on CAR T cell manufacturing is out in @BCD_AACR. We provide a comprehensive overview on recent trends and a…
1,612 followers
RT @abouelem: Our recent review on CAR T cell manufacturing is out in @BCD_AACR. We provide a comprehensive overview on recent trends and a…
3,309 followers
RT @abouelem: Our recent review on CAR T cell manufacturing is out in @BCD_AACR. We provide a comprehensive overview on recent trends and a…
2,972 followers
RT @abouelem: Our recent review on CAR T cell manufacturing is out in @BCD_AACR. We provide a comprehensive overview on recent trends and a…
2,972 followers
#OnlineFirst: A review article Scalable Manufacturing of CAR T Cells for Cancer Immunotherapy. @abouelem @ElsallabMagdi #CARTcell #celltherapy https://t.co/J08Co8egbY https://t.co/SmWqRXkc0e
4,433 followers
203 followers
RT @_TanyaBondar_: Affordable, robust, local production is a bottleneck for #CARTcell treatments as front line therapies. Just published in…
6,444 followers
RT @_TanyaBondar_: Affordable, robust, local production is a bottleneck for #CARTcell treatments as front line therapies. Just published in…
251 followers
RT @_TanyaBondar_: Affordable, robust, local production is a bottleneck for #CARTcell treatments as front line therapies. Just published in…
16,005 followers
RT @_TanyaBondar_: Affordable, robust, local production is a bottleneck for #CARTcell treatments as front line therapies. Just published in…
719 followers
RT @_TanyaBondar_: Affordable, robust, local production is a bottleneck for #CARTcell treatments as front line therapies. Just published in…
152 followers
RT @_TanyaBondar_: Affordable, robust, local production is a bottleneck for #CARTcell treatments as front line therapies. Just published in…
69 followers
RT @_TanyaBondar_: Affordable, robust, local production is a bottleneck for #CARTcell treatments as front line therapies. Just published in…
5,920 followers
RT @_TanyaBondar_: Affordable, robust, local production is a bottleneck for #CARTcell treatments as front line therapies. Just published in…
2,972 followers
RT @_TanyaBondar_: Affordable, robust, local production is a bottleneck for #CARTcell treatments as front line therapies. Just published in…
57 followers
RT @_TanyaBondar_: Affordable, robust, local production is a bottleneck for #CARTcell treatments as front line therapies. Just published in…
662 followers
Affordable, robust, local production is a bottleneck for #CARTcell treatments as front line therapies. Just published in @BCD_AACR and free to read: a review on Scalable Manufacturing of CAR T Cells for Cancer #Immunotherapy: https://t.co/itiKIoPSNe @aboue